期刊文献+

艰难梭菌无症状携带者危险因素分析 被引量:6

Risk factors of asymptomatic carriers of Clostridium difficile
原文传递
导出
摘要 目的探讨艰难梭菌无症状携带者的危险因素,为制定针对性的预防控制策略提供一定理论依据。方法采用单纯随机抽样,选取2014年9月21-27日于医院住院〉2周的患者128例为研究对象,收集其肛拭子标本,通过厌氧培养,经VIDAS荧光酶联免疫技术进行艰难梭菌毒素A/B检测,利用多重PCR技术进行艰难梭菌毒素基因检测,并利用SPSS 19.0软件进行艰难梭菌无症状携带者危险因素的多因素分析。结果 128例患者肛拭子标本中培养艰难梭菌阳性22株,阳性率为17.19%,均为无症状携带者;单因素分析显示,艰难梭菌无症状携带者在年龄、糖尿病史、使用抗菌药物、抗菌药物使用天数、使用氟喹诺酮类药物等方面差异有统计学意义(P〈0.05);logistic回归分析显示,近期使用抗菌药物和有糖尿病史可能为患者无症状携带艰难梭菌的独立危险因素,OR值分别为5.70(95%CI:1.69-19.21)和3.86(95%CI:1.21-12.26)。结论医院住院患者艰难梭菌培养阳性率较高,应加强对其监测和筛查,特别是对使用抗菌药物或患有糖尿病的患者更应密切关注。 OBJECTIVE To explore the risk factors of asymptomatic carriers of Clostridium difficile so as to formulate targeted prevention strategies.METHODS By means of single randomized sampling,a total of 128 patients who were hospitalized for more than two weeks from Sep 21,2014 to Sep 27,2014 were recruited as the study objects,then the anal swab specimens were collected for anaerobic culture,the C.difficile toxin A/B was detected by using VIDAS fluorescent enzyme-linked immunoassay,the toxin genes in the C.difficile strains were detected through the multiple PCR technique,and the multivariate analysis was performed for the risk factors of asymptomatic carriers of C.difficile with the use of SPSS 19.0software.RESULTS Of 128 anal swab specimens,22 were cultured positive for the C.difficile,with the positive rate 17.19%;all of the positive cases were asymptomatic carriers.The univariate analysis indicated that there was significant difference in the age,history of diabetic mellitus,use of antibiotics,duration of use of antibiotics,or use of fluoroquinolones(P〈0.05).The logistic regression analysis showed that the use of antibiotics and history of diabetic mellitus might be the independent risk factors for the asymptomatic carriers of C.difficile,and the OR values were 5.70(95%CI:1.69-19.21)and 3.86(95%CI:1.21-12.26),respectively.CONCLUSION The positive rate of culture of C.difficile is high in the hospitalized patients.It is necessary to strengthen the surveillance and screening and attach great importance to the patients who use antibiotics or have diabetic mellitus.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第11期2428-2430,共3页 Chinese Journal of Nosocomiology
基金 河南省高等学校重点科研基金资助项目(15A320070) 河南省医学科技攻关计划基金资助项目(201403039)
关键词 艰难梭菌 无症状携带 危险因素 流行病学 Clostridium difficile Asymptomatic carrier Risk factor Epidemiology
  • 相关文献

参考文献15

  • 1Magill SS,Edwards JR,Bamberg W,et al.Multistate pointprevalence survey of health care-associated infections[J].N Engl J Med,2014,370(13):1198-1208.
  • 2Mitchell BG,Gardner A.Mortality and Clostridium difficile infection:a review[J].Antimicrob Resist Infect Control,2012,1(1):20.
  • 3Surawicz CM,Brandt LJ,Binion D G,et al.Guidelines for diagnosis,treatment,and prevention of Clostridium difficile infections[J].Am J Gastroenterol,2013,108(4):478-498.
  • 4Riggs MM,Sethi AK,Zabarsky TF,et al.Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents[J].Clin Infect Dis,2007,45(8):992-998.
  • 5Brown KA,Khanafer N,Daneman N,et al.Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection[J].Antimicrob Agents Chemother,2013,57(5):2326-2332.
  • 6Ziakas PD,Zacharioudakis IM,Zervou F N,et al.Asymptomatic carriers of toxigenic C.difficile in long-term care facilities:a meta-analysis of prevalence and risk factors[J].PLoS One,2015,10(2):e117195.
  • 7Owens RJ,Donskey CJ,Gaynes R P,et al.Antimicrobial-associated risk factors for Clostridium difficile infection[J].Clin Infect Dis,2008,46(Suppl 1):S19-S31.
  • 8Qu H Q,Jiang ZD.Clostridium difficile infection in diabetes[J].Diabetes Res Clin Pract,2014,105(3):285-294.
  • 9Paredes-Sabja D,Cofre-Araneda G,Brito-Silva C,et al.Clostridium difficile spore-macrophage interactions:spore survival[J].PLoS One,2012,7(8):e43635.
  • 10Arvand M,Moser V,Schwehn C,et al.High prevalence of Clostridium difficile colonization among nursing home residents in Hesse,Germany[J].PLoS One,2012,7(1):e30183.

二级参考文献13

  • 1McCollum DL, Rodriguez JM. Detection, treatment, and prevention of Clostridium difficile infection. Clin Gastroenterol Hepatol, 2012,10: 581-592.
  • 2Stanley JD, Bartlett JG, Dart BW 4th, et al. Clostridium diffieile infection. Curt Probl Surg, 2013,50 : 302-337.
  • 3Finney JMT. Gastro-enterostomy for cicatrizing ulcer of the pylorus. Bull Johns Hopkins Hosp, 1893,4:53-55.
  • 4Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium diffieile- associated diarrhea with high morbidity and mortality. N Engl J Med, 2005, 353:2442-2449.
  • 5Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol, 2007,102: 2047-2057.
  • 6Tleyjeh IM, Abdulhak AB, Riaz M, et al. The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis. PLoS One, 2013,8:e56498.
  • 7Cohen SH, Gerding DN, Johnson S,et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol, 2010,31: 431-455.
  • 8Bauer MP, Kuijper EJ, van Dissel JT, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect, 2009, 15:1067-1079.
  • 9Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis, 2007,45:302-307.
  • 10Eiseman B, Silen W, Bascom GS,et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 1958,44:854-859.

共引文献5

同被引文献22

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部